@vikmahajan Per AMBOSS and UTD, although a macrolide is no longer recommended for MAC prophylaxis in patients taking cART, it is still recommended for patients with a CD4+ count < 50/mm3 who are not immediately started on effective cART (e.g., because they refuse ART). Can you describe (not copy) the UW question stem and what the correct/incorrect answers were?
Question stem: Patient with HHV8 untreated. Comes in with infections. CD4 = 45. Patient will start retrovirals and what other prophylaxis should be taken. Answer is only TMPSMX and not azithro, flucanzolje, or valacyclovir.
According to your description of the question, the table is not in contradiction. The table indicates that azithro / clarithro can be used for prophylaxis in patients with “no active infection + not on fully suppressive ART”